420 with CNW – Student-Organized Event Discusses Cannabis on Sidelines of Michigan Hash Bash

Every year, a Hash Bash festival is held in Ann Arbor as a day of having fun and entertainment. This year, law students at Michigan Law School worked with the organizers of the Hash Bash festival to host an event at the law school to discuss marijuana legalization politics.

This event was held yesterday (Sunday, April 7) while the Hash Bash took place on Saturday. The organizers of the event at Michigan Law School wanted to educate members of the public about issues related to marijuana. Several panelists made presentations on various issues.

Ari Goldstein, a law student who was one of the organizers, remarked that marijuana legalization brings entrepreneurial opportunities that haven’t been seen since the Great Depression, so every effort must be taken to prepare people to seize those opportunities.

Kevin Boehnke, who is a research fellow at Michigan University’s Department of Anesthesiology, revealed during his presentation that several patient studies point to the fact that more patients are opting for medical marijuana to manage pain instead of using prescription opioids.

The shift is due to the better symptom relief experienced by patients, and the concerns about the documented side effects of prescription opioids.

Another panelist, Gus Rosania (a professor of pharmacological sciences) handled the topic of natural vs. synthetic cannabis ingredients. Rosania dispelled the misconception that synthetic cannabis is different from natural cannabis.

He revealed that at the basic level, synthetic marijuana is chemically identical to natural marijuana, so it is hard to tell the two apart. He added that it was only because different ingredients could be isolated and made in a lab that it was possible to identify the different cannabinoids in marijuana.

Andrew Brisbo, the head of Michigan’s Bureau of Marijuana Regulation, was also in attendance to talk about the ramifications of the legalization of recreational cannabis in the state. He revealed that he had a huge task on his desk to put together a program for recreational cannabis implementation in just a year from the time the law was passed.

Brisbo intimated that one way that he was using to get everything done correctly is by engaging different stakeholders in order to tap their perspectives when putting together an implementation plan.

Many people in the audience expressed their frustration about how hard it was for them to get a medical cannabis prescription from their doctors. Brisbo expressed sympathy for their plight and revealed that it wasn’t easy to change attitudes about cannabis after such a long time of prohibition. He added that efforts were underway to give physicians more information about medical cannabis so that they can gradually warm up to prescribing it to their patients who qualify for such treatment.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America, Inc. (OTCQB: MCOA) welcome such engagements between regulators, patients, professors and other stakeholders since such interactions can result in better cannabis industry policies.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Leave a Reply